Marijuana Edibles & Infused Products

Health officials identify additive in patients with cannabis-related vaping illnesses, a move that could boost legal vape products

U.S. health officials on Friday singled out vitamin E acetate as a likely culprit in the vaping health crisis, reiterating that many of the suspect THC vape products were obtained from illicit sources rather than licensed cannabis businesses. While the exact cause remains unknown, marijuana industry officials said that identifying a possible culprit behind the […]

Read More

Offering consumers a face-to-face experience helps them remember a marijuana brand, experts advise

Whether it’s a cannabis-focused arts and music festival, a “garden party” or a tour that guides visitors from cultivation all the way to the sales floor, experts say that creating memories that stick with customers is among the most effective ways to build brand loyalty. In an industry constrained by regulations that limit cannabis advertising, […]

Read More

Curaleaf amends Cura Partners marijuana deal; antitrust hurdle cleared

Curaleaf, a Massachusetts-based, multistate cannabis operator, is amending the terms of its pending acquisition of Cura Partners because of changing market conditions. Curaleaf, which initially announced the proposed deal in May for an estimated price of almost $1 billion, will now issue 55 million of its shares instead of the original 95.6 million shares in the […]

Read More

Sales of marijuana edibles up in at least four states in wake of vape health scare

The vaping health crisis apparently has been good for the marijuana edibles sector, a sign that consumers are funneling more money into infused products instead of vaporizers. Since the first vape-related death was reported in August, retail sales of edibles have climbed steadily in four states while those of vaping products have declined, though the […]

Read More

More than 50% of Wisconsin vape products linked to illnesses contain cannabis

More than half the vape products the U.S. Food and Drug Administration (FDA) tested in its investigation into vaping illnesses in Wisconsin contained THC, the agency reported. Wisconsin does not have a full-strength medical marijuana program, but it is the first state to disclose test results of vape products under investigation after the nationwide health […]

Read More

Washington state temporarily bans flavored marijuana vaping products, targeting a third of top-selling MJ vapes

Washington state health regulators voted overwhelmingly on Wednesday to impose a temporary halt on the sale of flavored tobacco and marijuana vaporizer products, making it the second state after Massachusetts to ban cannabis vapes in some form. The Washington Board of Health voted 7-1 in favor of adopting the 120-day emergency ban, which is set […]

Read More

CA vape maker Kushy Punch in spotlight amid allegations of illegal cannabis products; firm says goods not for sale

Questions are swirling around a well-known California marijuana vaporizer manufacturer after its facility was raided by state authorities for allegedly manufacturing illegal cannabis vape cartridges. The case involving licensed manufacturer Kushy Punch – which contends the vape cartridges were set to be destroyed – comes as the industry is scrambling to respond to a health crisis […]

Read More

MA vaping ban, including cannabis products, expected to survive court challenge

A four-month ban in Massachusetts on the sale of all marijuana and tobacco vaping products is expected to remain in place. On Friday, U.S. District Judge Indira Talwani was “leaning toward” dismissing a temporary restraining order to stop the ban, which is being sought by the Vapor Technology Association, a national industry trade group, according […]

Read More

FDA warns against vaping cannabis products containing THC

The U.S. Food and Drug Administration on Friday issued an updated consumer alert warning people not use vaping products containing THC, though it makes no mention of recommendations for cannabis businesses. The statement from FDA Commissioner Norman Sharpless notes that “the FDA does not have enough data to identify the cause, or causes, of the […]

Read More